Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spring Kong

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|December 5, 2019
Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment StrategyChi-Leung Chiang, Albert C Y Chan, Keith W H Chiu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2007
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTVJian-Yue Jin, Munther Ajlouni, Qing Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?Jian-Yue Jin, Anxin Gu, Weili Wang, et al.
Translational Lung Cancer Research|December 9, 2017
Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalizationMichael MacManus, Sarah Everitt, Tanja Schimek-Jasch, et al.
Journal of Cancer|January 22, 2019
Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 PatientsMonica Cheng, Shruti Jolly, William O Quarshie, et al.
Frontiers in Oncology|January 10, 2022
Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisGuixiang Liao, Zhihong Zhao, Yuting Qian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2008
Utilize target motion to cover clinical target volume (ctv)--a novel and practical treatment planning approach to manage respiratory motionJian-Yue Jin, Munther Ajlouni, Feng-Ming Spring Kong, et al.
International Journal of Cancer|December 7, 2023
Low-dose radiation therapy mobilizes antitumor immunity: New findings and future perspectivesLaiyan Zhou, Yuanxin Liu, Yuanjun Wu, et al.
Journal of Radiation Oncology|September 15, 2015
Metabolic response assessment with <sup>18</sup>F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancerJingbo Wang, Ka Kit Wong, Morand Piert, et al.
Translational Lung Cancer Research|December 9, 2017
Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapyDirk De Ruysscher, Jianyue Jin, Tim Lautenschlaeger, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|December 5, 2019
Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment StrategyChi-Leung Chiang, Albert C Y Chan, Keith W H Chiu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2007
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTVJian-Yue Jin, Munther Ajlouni, Qing Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2020
Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?Jian-Yue Jin, Anxin Gu, Weili Wang, et al.
Translational Lung Cancer Research|December 9, 2017
Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalizationMichael MacManus, Sarah Everitt, Tanja Schimek-Jasch, et al.
Journal of Cancer|January 22, 2019
Modern Radiation Further Improves Survival in Non-Small Cell Lung Cancer: An Analysis of 288,670 PatientsMonica Cheng, Shruti Jolly, William O Quarshie, et al.
Frontiers in Oncology|January 10, 2022
Prognostic Role of Soluble Programmed Death Ligand 1 in Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisGuixiang Liao, Zhihong Zhao, Yuting Qian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2008
Utilize target motion to cover clinical target volume (ctv)--a novel and practical treatment planning approach to manage respiratory motionJian-Yue Jin, Munther Ajlouni, Feng-Ming Spring Kong, et al.
International Journal of Cancer|December 7, 2023
Low-dose radiation therapy mobilizes antitumor immunity: New findings and future perspectivesLaiyan Zhou, Yuanxin Liu, Yuanjun Wu, et al.
Journal of Radiation Oncology|September 15, 2015
Metabolic response assessment with <sup>18</sup>F-FDG PET/CT: inter-method comparison and prognostic significance for patients with non-small cell lung cancerJingbo Wang, Ka Kit Wong, Morand Piert, et al.
Translational Lung Cancer Research|December 9, 2017
Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapyDirk De Ruysscher, Jianyue Jin, Tim Lautenschlaeger, et al.
Pageof 16